Drug Manufacturer India

Espee Group, through its extensive network, identifies the best suitable manufacturing unit for API, Intermediates, Finished dosage, Tablets, Capsules, Injections, and Vials on LL and P2P manufacturing as per the customer's requirements.

Thursday, 10 July 2014

Tagged under: , , , ,

Global pharma manufacturing companies

Global pharma manufacturing companies like Pfizer, Novartis is facing an unprecedented crisis in terms of sales growth, profitability and discovery of new drugs for the last some years now. With increasing rate of patent expiry of several blockbusters and reduced spending on research, top multinational drug companies are facing a rather gloomy future in the years to come.

As per the source below are the problems faced by India in pharmaceutical sectors
  • Controlling prices of essential drugs has been a challenging task for several years in India as the pharmaceutical companies have not been cooperating with the government to achieve this basic social objective.
  • Online selling of prescription drugs to overseas customers by a group of traders from India without drug licenses and prescriptions is posing a big challenge to the regulatory authorities in the country. This fast growing illegal trade of medicines from India can thus seriously affect the reputation of the country as India is already major supplier of quality generics to the world markets.
  • India has been witnessing the trend of steadily increasing import of APIs, intermediates and excipients from China at very low prices for some years now. The government was concerned as these imports were posing a threat to domestic API industry.
  • The use of medical devices for various health conditions has increased considerably during the last ten years in the country. But there is no competent authority to check the quality and prices of medical devices and that situation has led to marketing of substandard products getting into the market at exorbitant prices.
  • The need for centralizing drug licensing was felt as the state drug authorities have been issuing licenses without any scrutiny of applications resulting in circulation of thousands of irrational and harmful combination drugs in the market.
  • Steady decline in the export of pharmaceuticals especially to the big markets like the US and Europe during last two years is yet another issue of great concern.

Pharma Manufacturing Companies in Ahmedabad | International Pharma Companies in India  

0 comments:

Post a Comment